169 related articles for article (PubMed ID: 32927467)
1. Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
Griffiths M; Yang J; Nies M; Vaidya D; Brandal S; Williams M; Matsui EC; Grant T; Damico R; Ivy D; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
Pediatr Res; 2020 Dec; 88(6):850-856. PubMed ID: 32927467
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
[TBL] [Abstract][Full Text] [Related]
3. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
[TBL] [Abstract][Full Text] [Related]
4. ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
Griffiths M; Yang J; Simpson CE; Vaidya D; Nies M; Brandal S; Damico R; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Rosenzweig EB; Hirsch R; Yung D; Nichols WC; Everett AD
Chest; 2021 Jul; 160(1):297-306. PubMed ID: 33609516
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.
Yang J; Nies MK; Fu Z; Damico R; Korley FK; Hassoun PM; Ivy DD; Austin ED; Everett AD
Am J Respir Crit Care Med; 2016 Nov; 194(10):1264-1272. PubMed ID: 27254543
[TBL] [Abstract][Full Text] [Related]
6. Circulating IGF system and treatment outcome in epithelial ovarian cancer.
Huang YF; Cheng WF; Wu YP; Cheng YM; Hsu KF; Chou CY
Endocr Relat Cancer; 2014 Apr; 21(2):217-29. PubMed ID: 24273235
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
[TBL] [Abstract][Full Text] [Related]
8. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
[TBL] [Abstract][Full Text] [Related]
9. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survival.
Torres G; Yang J; Griffiths M; Brandal S; Damico R; Vaidya D; Simpson CE; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
Pulm Circ; 2023 Apr; 13(2):e12235. PubMed ID: 37152104
[TBL] [Abstract][Full Text] [Related]
11. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
12. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
[TBL] [Abstract][Full Text] [Related]
13. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
Damico R; Kolb TM; Valera L; Wang L; Housten T; Tedford RJ; Kass DA; Rafaels N; Gao L; Barnes KC; Benza RL; Rand JL; Hamid R; Loyd JE; Robbins IM; Hemnes AR; Chung WK; Austin ED; Drummond MB; Mathai SC; Hassoun PM
Am J Respir Crit Care Med; 2015 Jan; 191(2):208-18. PubMed ID: 25489667
[TBL] [Abstract][Full Text] [Related]
14. Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severity.
Nies MK; Yang J; Griffiths M; Damico R; Zhu J; Vaydia D; Fu Z; Brandal S; Austin ED; Ivy DD; Hassoun PM; Van Eyk JE; Everett AD
Pulm Circ; 2022 Apr; 12(2):e12039. PubMed ID: 35514776
[TBL] [Abstract][Full Text] [Related]
15. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.
Chen JY; Griffiths M; Yang J; Nies MK; Damico RL; Simpson CE; Vaidya RD; Brandal S; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Pediatr; 2020 Aug; 223():164-169.e1. PubMed ID: 32711743
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
17. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
20. Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.
Kendrick ZW; Firpo MA; Repko RC; Scaife CL; Adler DG; Boucher KM; Mulvihill SJ
HPB (Oxford); 2014 Jul; 16(7):670-6. PubMed ID: 24308545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
